Is substance use disorder more prevalent in patients with hidradenitis suppurativa?
|dc.description.abstract||Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition that disproportionately affects women and is associated with significant physical and psychosocial impact. Recent studies have reported an increased prevalence of substance abuse among patients with HS, including increased alcohol, opioid, and cannabis use. Whether substance use disorder is more prevalent among patients with HS is controversial because these data come from small studies and a major confounder is that patients with HS are often prescribed opioids for HS-associated pain. This review summarizes the current literature on substance use in HS to investigate whether substance use disorder is more likely in this patient population. We also highlight possible cofounders and areas of unmet need in HS that are potential causes of abuse, such as adequate pain control and impaired quality of life, and suggest opportunities for provider intervention. Evidence suggests that there is an increased prevalence of substance use disorder in patients with HS, but the full extent is still difficult to determine. However, with early screening and appropriate referrals to specialists, dermatologic providers may properly intervene and prevent substance use disorder in patients with HS.||en_US|
|dc.description.sponsorship||This study was supported in part by Yale School of Medicine, Office of Student Research.||en_US|
|dc.relation.ispartof||International Journal of Women's Dermatology|
|dc.title||Is substance use disorder more prevalent in patients with hidradenitis suppurativa?||en_US|